Australia's CurveBeam AI rises as co fears no material impact from US tariffs
Shares of CurveBeam AI CVB.AX rise as much as 6.8% to A$0.094, their biggest intraday pct gain since March 31
The medical equipment manufacturer says that it expects no material impact from tariffs announced by U.S. President Donald Trump
Co highlights that it conducts majority of its manufacturing activities within the U.S.
Shares of co fell 16.2% on Monday, in line with the markets sell-off seen globally amid recession fears
Shares of CurveBeam down 31.1%, YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
SpaceX IPO Guide: Can You Buy SpaceX IPO Shares on Robinhood? How Can Investors in Asia and Europe Buy SpaceX IPO Shares?

Anthropic Revenue Surpasses OpenAI for First Time, IPO as Early as October

Meta Is About to Launch a Consumer-Facing AI Model, and OpenAI Is About to Have Its IPO, Making Now a Good Time to Buy Meta Stock

IonQ vs. Rigetti Computing: Which Quantum Computing Stock Has the Edge Now?

Amazon Stock: 4 Pillars Supporting a Buy Thesis in a Cautious Market

Tradingkey







